BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7978838)

  • 21. Murine TIMP-2 gene-targeted mutation.
    Caterina J; Caterina N; Yamada S; Holmbäck K; Longenecker G; Shi J; Netzel-Arnett S; Engler J; Yermovski A; Windsor J; Birkedal-Hansen H
    Ann N Y Acad Sci; 1999 Jun; 878():528-30. PubMed ID: 10415763
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts.
    Li H; Bauzon DE; Xu X; Tschesche H; Cao J; Sang QA
    Mol Carcinog; 1998 Jun; 22(2):84-94. PubMed ID: 9655252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.
    Imai K; Ohuchi E; Aoki T; Nomura H; Fujii Y; Sato H; Seiki M; Okada Y
    Cancer Res; 1996 Jun; 56(12):2707-10. PubMed ID: 8665498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Function of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2).
    Sugiura T; Berditchevski F
    J Cell Biol; 1999 Sep; 146(6):1375-89. PubMed ID: 10491398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
    Lehti K; Lohi J; Valtanen H; Keski-Oja J
    Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.
    von Bredow DC; Cress AE; Howard EW; Bowden GT; Nagle RB
    Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):965-72. PubMed ID: 9560329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
    Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
    Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of metalloproteinase-2 by membrane type metalloproteinase expressed on human mesangial cell membrane.
    Tomosugi N; Sato H; Seiki M; Yamaya H; Yuri T; Nakamura M; Nakazawa T; Asaka M; Ishikawa I
    Contrib Nephrol; 1996; 118():135-40. PubMed ID: 8744050
    [No Abstract]   [Full Text] [Related]  

  • 29. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
    Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
    Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombin rapidly and efficiently activates gelatinase A in human microvascular endothelial cells via a mechanism independent of active MT1 matrix metalloproteinase.
    Nguyen M; Arkell J; Jackson CJ
    Lab Invest; 1999 Apr; 79(4):467-75. PubMed ID: 10211999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
    Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M
    EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Stromal proteases in the progression of breast cancer].
    Foidart JM
    Bull Mem Acad R Med Belg; 1997; 152(5):229-35; discussion 235-7. PubMed ID: 9532865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
    Fridman R; Toth M; Peña D; Mobashery S
    Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An elastinolytic enzyme detected in the culture medium of human arterial smooth muscle cells.
    Okada Y; Katsuda S; Okada Y; Nakanishi I
    Cell Biol Int; 1993 Sep; 17(9):863-9. PubMed ID: 8220313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invasiveness and MMP expression in pancreatic carcinoma.
    Yang X; Staren ED; Howard JM; Iwamura T; Bartsch JE; Appert HE
    J Surg Res; 2001 Jun; 98(1):33-9. PubMed ID: 11368535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of gelatinolytic activity by oesophageal and colon carcinoma cell lines.
    Della Porta P; Ryan NM; Collins KJ
    Biochem Soc Trans; 1995 May; 23(2):391S. PubMed ID: 7672425
    [No Abstract]   [Full Text] [Related]  

  • 37. Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species.
    Lafleur MA; Hollenberg MD; Atkinson SJ; Knäuper V; Murphy G; Edwards DR
    Biochem J; 2001 Jul; 357(Pt 1):107-15. PubMed ID: 11415441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased type IV collagen-degrading activity in metastases originating from primary tumors of the human colon.
    Karakiulakis G; Papanikolaou C; Jankovic SM; Aletras A; Papakonstantinou E; Vretou E; Mirtsou-Fidani V
    Invasion Metastasis; 1997; 17(3):158-68. PubMed ID: 9702942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiproliferative and antiinvasive effects of carboxyamido-triazole on breast cancer cell lines.
    Lambert PA; Somers KD; Kohn EC; Perry RR
    Surgery; 1997 Aug; 122(2):372-8; discussion 378-9. PubMed ID: 9288143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gelatinases/type IV collagenases in jaw cyst expansion.
    Teronen O; Salo T; Konttinen YT; Rifkin B; Vernillo A; Ramamurthy NS; Kjeldsen L; Borregaard N; Sommerhoff CP; Sorsa T
    Ann N Y Acad Sci; 1994 Sep; 732():486-8. PubMed ID: 7978847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.